CMS's GUIDE dementia-care model puts payment behind five quality measures for the first time in Performance Year 2026. For family caregivers, the surveys and medication tracking changed, while daily team support and respite did not. GUIDE is an 8-year voluntary national model running July 1, 2024-June 30, 2032. According to CMS's July 2026 fact sheet, it aims to improve quality of life, support unpaid caregivers, and help people remain at home.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Register through CMS’s official page — Use this page to review requirements and register directly.
- Read the official guidance from CMS — Use this primary source to verify the official guidance.
Table of Contents
- Why 2026 affects payment
- What changed in the two surveys
- How medication safety is tracked
- Who can stay in GUIDE
- What support stays the same
Why 2026 affects payment
Performance Year 2026 runs July 2026-June 2027. According to Elli Cares' summary of the CMS manual, it is the first year all five measures can adjust payment. That adjustment changes monthly dementia-care payments by up to +10% or down to -3.5%.
The five measures span care coordination and medications, patient quality of life, caregiver support, plus cost and use from claims. The cost piece is total per-capita cost. The use piece is long-term nursing-home stay. Families still face surveys plus claims tracking.
What changed in the two surveys
The patient measure is now Quality of Life for Patients Living with Dementia, or QoL-PLWD. It scores the PROMIS-10 physical and mental parts separately. Scores adjust for baseline score, dementia severity, caregiver presence, and residence. That means a change counts in context, not as a raw number alone.
The caregiver measure is now Caregiver-Reported Impact in Dementia, or CID. It uses the 22-item Zarit Burden Interview completed by identified caregivers. Lower burden is better. That score is worth -1% to +3% in the payment adjustment.
How medication safety is tracked
High-risk medication reporting no longer uses a participant workbook. According to CMS's Performance Measurement Manual, version 3.0 dated May 18, 2026 made the switch. The replacement is the NCQA claims-based Drugs to Avoid in the Elderly measure.
It adds antipsychotics and benzodiazepines. For caregivers, the practical change is less paperwork. Tracking now happens through pharmacy claims rather than clinic reports.
Who can stay in GUIDE
Effective July 1, 2026, residents of dedicated memory-care units are ineligible for GUIDE. They are disenrolled after a 15-day transition.
Residents of residential-care communities face a different rule. They need a CMS-approved partnership before receiving GUIDE services. Families considering a move should check the setting first:.
- Home or other eligible community setting keeps GUIDE access
- Dedicated memory-care unit ends GUIDE eligibility
- Residential-care community requires an approved partnership
What support stays the same
Every aligned family still gets an interdisciplinary team with a care navigator. The team provides 24/7 access to a member or helpline, including caregiver calls. Caregiver education and support continue, including respite.
Respite has a firm cap and timeline. It is capped at $2,625 per eligible patient for July 1, 2026-June 30, 2027. It covers only moderate or severe dementia with an unpaid caregiver, is billed to CMS by the provider, and does not carry over, so plan breaks early.
You Might Also Like
- MRI and ARIA Monitoring With At-Home Leqembi in 2026: What Changed and What Did Not for People With Mild Cognitive Impairment
- The WHO 45% Modifiable Dementia Risk Estimate in 2026: What Is Established and What Is Still Being Studied for Adults Over 65
- Injection Training for the 2026 At-Home Leqembi Regimen: What Changed and What Did Not for People With Mild Cognitive Impairment





